The reoxidation of cytoplasmic reducing equivalents in Ehrlich ascites tumor cells.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D003580:Cytochromes / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism*; D003864:Depression, Chemical; D005947:Glucose / Q000494:pharmacology; D006019:Glycolysis; D007700:Kinetics; D051379:Mice; D008861:Microsomes / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D009840:Oligomycins / Q000494:pharmacology; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D011048:Polarography; D011123:Polyploidy; D011773:Pyruvates / Q000494:pharmacology; D012402:Rotenone / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012995:Solubility; D013053:Spectrophotometry; D013268:Stimulation, Chemical; D013696:Temperature; D013997:Time Factors; D014475:Uncoupling Agents; D014812:Vitamin K / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D003580:Cytochromes; D009840:Oligomycins; D011773:Pyruvates; D014475:Uncoupling Agents; D012402:Rotenone; D014812:Vitamin K; D005947:Glucose